Home » Topics » BioWorld Science

BioWorld Science
RSS

PolyHeme phase II results in trauma patients announced

May 24, 1996

RF-1051 receives orphan drug status in PWS

May 24, 1996

Amgen begins clinical testing of leptin

May 24, 1996

Intrachol receives U.S. patent protection

May 24, 1996

Orphan Medical discontinues glucaric acid development

May 24, 1996

Zoledronate effective in Paget's disease patients

May 24, 1996

Ibandronate demonstrates bone-preserving effects in phase II

May 24, 1996

Ortho claims agents for osteoporosis

May 24, 1996

Marimastat continues to show clinical efficacy

May 24, 1996

SU-101 interim results announced at ASCO

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...